Priser
Platform
Blog
Om os
Download
PMED
Piu' Medical
Borsa Italiana
0

Markedsdata leveret af TwelveData og Morningstar

Aktiemarkedet kan gå både op og ned. Selvom investeringer i aktier historisk set har givet investorer et positivt afkast på langt sigt, er der ingen garanti for fremtidige afkast. Der er derfor en risiko for, at du ikke får de investerede penge tilbage.

INVESTER I PIU' MEDICAL MED ENDAVU: Køb Piu' Medical ($PMED) aktier gennem Endavu’s investeringsplatform. Hos Endavu kan du købe og sælge aktier i Piu' Medical, og handle med aktier, fraktionaler, ETF'er og andre finansielle instrumenter. Endavu tilbyder handel uden kurtage på amerikanske aktier. Endavu tilbyder lav kurtage på tværs af aktier. Handl med over 30.000 forskellige aktier og udenfor markedsåbningstider.

Om

Piu Medical S.p.A. is an Italian company specializing in the retail distribution of pharmaceutical and parapharmaceutical products through a network of pharmacies. Its primary activities include the sale of prescription drugs, over-the-counter (OTC) medicines, dietary supplements, medical devices, paramedical products, personal care and wellness items, homeopathic medicines, and cosmetics. The company also provides health services such as diagnostic testing, blood parameter analysis for glycemia, cholesterol, and triglycerides, rapid screening tests, nutritional consultations, remote medical assistance, monitoring, and telemedicine. These operations are conducted via physical pharmacies located in Italy and an online platform, serving consumers seeking accessible healthcare solutions. Operating in the healthcare sector within pharmaceutical retail, Piu Medical S.p.A. focuses on integrating health, prevention, and wellbeing services. Founded prior to its public listing and headquartered in Castronno, Italy, it plays a role in modernizing pharmacy services through technology and community-oriented care.

Information

TickerPMED
Land
Italien
Antal medarbejdere77
Hjemmesidepiumedical.com
SektorSundhed
IndustriApoteksforhandlere

Analytikerskøn

Baseret på 1 analytiker

Stærkt købKøbHoldSælgStærkt sælg
0%100%0%0%0%